PALO ALTO, Calif.--(BUSINESS WIRE)--The U.S. neurological devices market looks set for appreciable growth, especially due to the major unmet clinical need for the treatment of neurological disorders. Moreover, the neurological devices market addresses large patient pools. The United States estimated around 140.0 million people afflicted with neurological disorders (chronic pain, migraine, essential tremor, stroke, Alzheimer’s disease, epilepsy, Parkinson’s disease, and dystonia), thus highlighting the underlying growth.
